Corcept Therapeutics CORT
NASDAQ CORT
$115.64 +0.90 (+0.78%)
As of: Sep 30, 2026 · 3:54 PM EDT

Corcept Therapeutics (CORT) Revenue (2012 - 2026)

Updated

Corcept Therapeutics (CORT) posted Revenue of $256.15 million for Q2 2026, up 31.7% from $194.43 million a year earlier and up 55.3% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Revenue (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Corcept Therapeutics was $830.81 million, up 16.0% year-over-year; for FY2025, it came in at $761.41 million, up 12.8% from FY2024.

  • Annual Revenue has increased for 13 consecutive years, with a five-year compound annual growth rate of 16.6% (FY2020 to FY2025).
  • In prior years, Corcept Therapeutics' Revenue was $675.04 million in FY2024 (+39.9%), $482.38 million in FY2023 (+20.0%), $401.86 million in FY2022 (+9.8%) and $365.98 million in FY2021 (+3.4%).
  • The Q2 2026 figure stands as the highest quarterly Revenue in data going back to Q2 2012.
  • On a year-over-year basis, Revenue has increased in each of the last 21 quarters, with growth averaging 21.2% over the last eight quarters.
  • Across the past five years, year-over-year growth in Revenue ran from 4.3% in Q4 2022 to 47.7% in Q3 2024.
  • According to Business Quant data, Revenue for the three prior quarters was $164.9 million (Q1 2026), $202.13 million (Q4 2025) and $207.64 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Corcept Therapeutics 12.40 Bn 10.96 Bn 252.09 Mn 256.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 256.15 Mn
Mar 31, 2026 164.90 Mn
Dec 31, 2025 202.13 Mn
Sep 30, 2025 207.64 Mn
Jun 30, 2025 194.43 Mn
Mar 31, 2025 157.21 Mn
Dec 31, 2024 181.89 Mn
Sep 30, 2024 182.55 Mn
Jun 30, 2024 163.80 Mn
Mar 31, 2024 146.81 Mn
Dec 31, 2023 135.41 Mn
Sep 30, 2023 123.60 Mn
Jun 30, 2023 117.72 Mn
Mar 31, 2023 105.65 Mn
Dec 31, 2022 103.06 Mn
Sep 30, 2022 101.73 Mn
Jun 30, 2022 103.39 Mn
Mar 31, 2022 93.69 Mn
Dec 31, 2021 98.82 Mn
Sep 30, 2021 96.13 Mn
API Access

Corcept Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CORT&period=max&api_key=YOUR_API_KEY